Germany’s federal health committee G-BA has updated its procedural framework to refine how market exclusivity and patient data impact the assessment of innovative drugs.
International patent regimes provide the basic legal infrastructure for protecting pharmaceutical inventions across jurisdictions. They determine which inventions are patentable, how long protection lasts, and how far a single filing can be leveraged in multiple territories.
A multilayered framework of intellectual property rights and regulatory protections exists across the EU to support the investment required for pharmaceutical research and development.
